|
|
Open |
All Faculty |
Non-Federal |
Sarcomas |
The Liddy Schriver Sarcoma Initiative
Research targeted at finding cures for sarcomas, as well as research that attempts
to develop more effective treatment regimens than are currently available.
|
New Opportunity |
|
May 15 (LOI) |
All Faculty |
Non-Federal |
Drug Discovery |
The Harrington Discovery Institute - Harrington Scholar-Innovator Grant
Provide funding for physician-scientists seeking to accelerate promising
drug discoveries into novel treatments for patients.
Focus of project must be fundamental discovery (elucidation of novel targets
and leads), new drugs and biologics or drug-device combinations.
|
|
|
May 20 |
All Faculty |
Federal |
Molecular Analysis |
Early-Stage Innovative Molecular Analysis Technology
Development for Cancer Research (R21)
Molecular analysis technologies with technical innovation to affect and transform
investigations exploring the molecular and cellular bases of cancer.
Due Date:
|
May 20
|
Amount & Project Period:
|
$500,000 total over 3 years
|
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA-CA-13-001
|
Validation and Advanced Development of Emerging Molecular Analysis
Technologies for Cancer Research (R33)
Advanced development of emerging molecular and cellular analysis technologies and technologies and
technical/analytical validation in an appropriate cancer-relevant biological system.
Due Date:
|
May 20
|
Amount & Project Period:
|
$900,000 total over 3 years
|
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071 |
RFA Link:
|
RFA:
CA-13-002
|
|
|
|
|
May 20 |
All Faculty |
Federal |
Cancer Biology |
Early-Stage Development of Innovative Technologies for Biospecimen Science
Advanced development of emerging molecular and cellular analysis technologies and
technical/analytical validation in an appropriate cancer-relevant biological system.
Due Date:
|
May 20
|
Amount & Project Period:
|
$500,000 total over 3 yrs
|
|
Eligibility:
|
All Faculty Ranks |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA: CA-13-003
|
|
|
|
May 20 |
All Faculty |
Federal |
Biospecimens |
Validation and Advanced Development of Emerging Technologies for Biospecimen Science
Advanced development and validation of cancer-relevant technologies addressing issues related to pre-analytical
variations in collection, processing, handling, and storage of biospecimens.
Due Date:
|
May 20
|
Amount & Project Period:
|
$900,000 total for 3 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA: CA-13-004
|
|
|
|
May 20 |
All Faculty |
Federal |
Provocative Questions |
Research Answers to NCI's Provocative Questions
Research projects designed to use sound and innovative research strategies to
solve specific problems and paradoxes in cancer research.
Due Date:
|
May 20 (LOI)
June 20 (App)
|
Amount & Project Period:
|
R01:
No Funding Limit - 4 years
R21: $275,000 total over 2 years |
|
Eligibility:
|
All Faculty |
Contact:
|
Linda Nolan, x6071
|
RFA Links:
|
Group A - Cancer prevention and risk
(R01: RFA-CA-12-015)
&
(R21: RFA-CA-12-016)
Group B - Mechanisms of tumor development & recurrence
(R01: RFA-CA-12-017) & (R21:
RFA-CA-12-018)
Group C - Cancer detection, diagnosis, and prognosis
R01: RFA-CA-12-019 & R21:
RFA-CA-12-020
Group D - Specific unsolved problems related to the development and use of new therapeutic agents.
R01: RFA-CA-12-021 & R21:
RFA-CA-12-022
|
|
 |
|
May 23 (LOI) |
Various |
Non-Federal |
Ovarian |
Ovarian Cancer Research Fund Grant Opportunities
Program Project Development Grant
For ovarian cancer research projects that may involve several investigators
within one institution or collaborations among groups at multiple institutions.
Anne Schreiber Mentored Investigator Award
Support postdoctoral trainees working under the supervision of an experienced
mentor in ovarian cancer.
Due Date:
|
May 23 @ 5:00 pm EST
August 23 - Invited submissions
|
Amount & Project Period:
|
$75,000 over 2 years
|
|
Eligibility:
|
Clinical and Postdoctoral fellows
90% research effort for this award is required.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
Ann Schreiber Mentored Investigator Award
|
Liz Tilberis Scholars Early Career Awards
To support junior investigators in their first faculty appointment with significant
time commitment to research and academic endeavors in ovarian cancer.
Due Date:
|
May 23 @ 5:00pm EST (LOI)
August 23 - Invited submissions
|
Amount & Project Period:
|
$150,000/yr for 3 years
|
|
Eligibility:
|
Open to Gynecologic and Medical Oncology
physician scientists and PhD Scientists.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
Liz Tilberis Scholars Early Career Awards
|
|
New Opportunity |
|
May 24 |
Sr Faculty |
Non-Federal |
Prostate Cancer |
2013 PCF Challenge Award
Support large-scale metastatic prostate cancer research projects focused
on funding Treatment Sciences: Investigations of new ideas in man or laboratory support of a high-impact
clinical investigation with a high probability of near-term patient benefit.
Due Date:
|
May 24
|
Amount & Project Period:
|
$1,000,000 total over 2 years.
|
|
Eligibility:
|
Teams of 3 or more experienced investigators.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
2013 PCF Challenge Award
|
|
|
|
May 25 |
All Faculty |
Federal |
All Areas |
NCI Program Project Applications
Program projects may address basic, translational, clinical and/or population-based studies. Projects
must consist of at least three components sharing a common theme, focus and/or overall objective.
Due Date:
|
May 25
|
Amount & Project Period:
|
No Funding Limit - 5 years |
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-005
|
|
New Opportunity
|
|
May 31 |
All Faculty |
Non-Federal |
Lung Cancer |
Lung Cancer Research Foundation 2013 Research Grants
Support funding for research in all aspects of lung cancer.
|
|
Doctors Cancer Foundation |
Non-Federal |
Facilitated App*
|
|
May 31 |
Junior Faculty |
Non-Federal |
Clinical Research |
The Doctors Cancer Foundation - Management of Cancer
Support young scientists' innovative projects with a strong interest in cancer stem cells,
microRNAi agents, epigenetic agents, as well as many others; leading to clinical trials.
*The Moffitt Foundation will facilitate this application. Contact
Shaina Sine for assistance.
|
New Opportunity |
|
June 5 |
All Faculty |
Federal |
Translational Projects |
Academic-Industrial Partnerships for Translation of
In vivo
Imaging Systems for Cancer Investigations
Supports research partnerships formed by academic and industrial investigators to
accelerate the translation of either preclinical or clinical in vivo imaging systems
and/or methods that are designed to solve or targeted cancer problem.
Due Date:
|
June 5
|
Amount & Project Period:
|
No Funding Limit - 5 years |
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-169
|
|
|
New Opportunity
|
|
June 5 |
All Faculty |
Federal |
Health Literacy |
Understanding and Promoting Health Literacy
Encourage methodological, intervention and dissemination research for understanding
and promoting health literacy.
Due Date:
|
June 5
|
Amount & Project Period:
|
No Funding Limit - 5 years
|
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071 |
RFA Link:
|
PAR-13-130
|
|
|
|
June 5 |
All Faculty |
Federal |
Alcohol/Cancer |
Mechanisms of Alcohol-associated Cancers
Supports a broad range of research into the mechanisms by which alcohol contributes to carcinogenesis.
Due Date:
|
June 5
|
Amount & Project Period:
|
No Funding Limit - 5 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-146
|
|
New Opportunity |
June 5 (R01)
June 16 (R21) |
All Faculty |
Federal |
Chronic Illness |
Innovative Research Methods: Prevention and Management of Symptoms
in Chronic Illness
Update randomized control trial (RCT) design using practical, innovative, novel research methods that
may produce more effective outcomes.
Due Date:
|
R01 - June 5
R21 -
June 16
|
Amount & Project Period:
|
R01:
$350,000/yr for 4 years
R21: $275,000 total over 2 years |
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
R01:
PA-13-165
| R21:
PA-13-167
|
|
|
June 5 (R01)
June 16 (R21) |
All Faculty |
Federal |
Heme/Malignancies |
Biomarkers for Early Detection of Hematopoietic Malignancies
Support projects on the development and validation of biomarkers for early detection, prediction of progression, and
recurrence of hematopoietic malignancies and for risk assessment of primary and secondary hematopoietic malignancies.
Due Date:
|
R01 - June 5
R21 - June 16
|
Amount & Project Period:
|
R01: No Funding Limit - 5 years
R21: $275,000 total for 2 years |
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
R01:
PA-12-221
|
R21: PA-12-220
|
|
|
June 5 (R01)
June 16 (R21) |
All Faculty |
Federal |
CIPN |
Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy
Support projects that lead to a molecular understanding of chemotherapy-induced peripheral neuropathy (CIPN)
Due Date:
|
R01 - June 5
R21 -
June 16
|
Amount & Project Period:
|
R01: No Funding Limit - 5 years
R21: $275,000 total over 2 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
R01:
PA-12-082
|
R21: PA-12-083
|
|
|
June 5 (R01)
June 16 (R01) |
All Faculty |
Federal |
Cancer Detection |
Identifying Non-coding RNA Targets for Early Detection of Cancer
Non-coding RNAs (ncRNAs) and targets in pre-neoplastic lesions and early stage cancers; usefulness of stable microRNAs (miRNAs) and ncRNAs to
predict progression to cancer and as biomarkers for early cancer detection and screening.
Due Date:
|
P01 - June 5
R21 -
June 16
|
Amount & Project Period:
|
R01: No Funding Limit - 5 years
R21: $275,000/yr for 2 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan,
x6071
|
RFA Link:
|
R01:
PA-12-213
|
R21: PA-12-214
|
|
|
|
June 5 |
All Faculty |
Federal |
Alcohol/Cancer |
Mechanisms of Alcohol-associated Cancers
Supports a broad range of research into the mechanisms by which alcohol contributes to carcinogenesis.
Due Date:
|
June 5
|
Amount & Project Period:
|
No Funding Limit -
5 Years |
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-146
|
|
New Opportunity |
June 7 (LOI)
July 17 (App) |
Sr. Investigators |
Federal |
Comparative
Effectiveness |
Patient Centered Outcomes Research (PCOR)
Institutional Mentored Career Development Program
To support the career development of post-doctoral and junior
research and clinical doctorate faculty scholars in comparative
effectiveness research methods, applied to patient-centered outcomes.
Due Date:
|
June 7 (LOI)
July 17 (App)
|
Amount & Project Period:
|
Total annual costs not to exceed $1,000,000 for 5 years
|
|
Eligibility:
|
Established Investigators - only 1 PI allowed.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
HS-13-008
|
|
New Opportunity |
June 8 (LOI)
July 8 (App) |
All Faculty |
Federal |
Genomics |
Centers of Excellence in Genomics Science (CEGS)
A Center for advanced genome research will support a multi-investigator,
interdisciplinary team to develop innovative genomic approaches to
address a particular biomedical problem.
Due Date:
|
June 8 (LOI)
July 8 (App)
|
Amount & Project Period:
|
$2,000,000/yr for 3 years
|
|
Eligibility:
|
All Faculty
(The CEGS program does not
permit multiple PDs/PIs).
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-198
|
|
|
New Opportunity
|
June 10 (LOI)
July 10 (App) |
Principal Investigators |
Federal |
Pathogen-induced
Cancer |
Revisions to Awards for Research in Detection of Pathogen-Induced
Cancer (DPIC)
Research to assess molecular signatures associated with risk and early detection of pathogen-induced
cancer and chronic inflammation associated with progression to invasive cancer.
Due Date:
|
June 10 (LOI)
July 10 (Application)
|
Amount & Project Period:
|
$150,000/yr for 2 years
(Project period may
not exceed the parent grant's remaining years).
|
|
Eligibility:
|
Principal Investigators must have an active
parent grant award with the same mechanism (e.g. P50, P01, R01, U01)
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
P50:
PAR-13-170
| P01:
PAR-13-171
R01:
PAR-13-172
| U01:
PAR-13-173
|
|
New Opportunity |
June 10 (LOI)
July 10 (App) |
Principal Investigators |
Federal |
Imaging/Biomarkers |
Revision Applications to Awards for Research on Imaging and Biomarkers
for Early Cancer Detection
Support research that combines imaging and biomarker approaches to improve screening,
early detection and diagnosis by integrating multi-modality imaging
strategies and multiplexed biomarker methodologies.
Due Date:
|
June 10 (LOI)
July 10 (App)
|
Amount & Project Period:
|
$150,000/yr for 2 years (Not to exceed remaining years of parent award).
|
|
Eligibility:
|
Principal Investigators with active parent award of same mechanism.
|
Contact:
|
Linda Nolan, x6071
|
RFA Links:
|
P50:
PAR-13-174 | P01:
PAR-13-175
R01: PAR-13-177 | U01:
PAR-13-176
|
|
New Opportunity
|
|
June 12 (Pre-App)
|
Sr Faculty |
Federal |
Ovarian |
Congressionally Directed Medical Research Programs (CDMRP)
- Ovarian Cancer Research Program (OCRP) Teal Innovator Award
Supports an individual from any field principally outside of, but not
exclusive of, ovarian cancer,to pursue novel, visionary, high-risk
ideas that could lead to the elimination of ovarian cancer.
Applicants must demonstrate national or international recognition
in their fields.
Due Date:
|
June 12 (Pre-App)
August 28 (Invited Submissions)
|
Amount & Project Period:
|
$2,500,000 total over 5 years
|
|
Eligibility:
|
Sr Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-OCRP-TIA
|
|
|
|
|
June 12 (Pre App) |
Jr Faculty |
Federal |
Ovarian Cancer |
CDMRP Ovarian Cancer Academy Award - Early Career Investigator
Supports the addition of early career investigators to a virtual academy that will provide intensive
mentoring, national networking, and a peer group. A designated mentor experienced in ovarian cancer research
with ovarian cancer funding and preliminary data are required. And an institutional match of $50,000 per year is required.
Due Date:
|
June 12 (Pre-App)
August 28 (Invited submission)
|
Amount & Project Period:
|
$725,000 total over 5 years
|
|
Eligibility:
|
Within first 3 years of faculty position. May be
tenure or non-tenure track.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-OCRP-OCA
|
|
|
|
|
June 12 (Pre-App) |
Postdocs/Jr. Faculty |
Federal |
Ovarian Cancer |
CDMRP - Ovarian Cancer Research Program Pilot Award
Support innovative, high-risk/high-reward research. Innovation and impact are important
review criteria. Preliminary data are not required, but are allowed. Clinical
trials are not allowed.
Optional Nested Teal Postdoctoral Scholar: applications from postdocs that meet the criteria outlined
will qualify for a higher level of funding.
Due Date:
|
June 12 (Pre-app)
August 28 (Invited Submissions)
|
Amount & Project Period:
|
$225,000 total over 2 years
$300,000 total over 3 years*
*With a qualified nested Teal Postdoctoral Scholar
Project Period.
|
|
Eligibility:
|
Postdocs or above.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-OCRP-PA
|
|
|
New Opportunity
|
|
June 12 |
Postdocs |
Federal |
Informatics |
NLM Independent Career Development Award for
Biomedical Informatics
To support the transition of postdocs with at least two years of training in
biomedical informatics from the mentored to the independent stage
of their careers by providing "protected time" for their research.
Due Date:
|
June 12
|
Amount & Project Period:
|
Up to $85,000 salary support (including benefits)/yr for 3 years
Up to $50,000 research support/yr for 3 years
|
|
Eligibility:
|
Postdoctoral fellows who have completed 2 years of training
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-10-195
|
|
|
|
June 12 |
Postdocs/Fellows
Jr Faculty |
Federal |
Career Development |
NCI Mentored Research Scientist Development Award to Promote Diversity
Provide support and protected time for career development for individuals representative of groups shown
to be underrepresented in health related-sciences (biomedical, behavioral
or clinical) leading to research independence.
Due Date:
|
June 12
|
Amount & Project Period:
|
Stipend: $100,000/yr (75% effort commitment required)
Research Costs: $30,000/yr
|
|
Eligibility:
|
Postdoc fellows
Assistant professors within 2 years of appointment
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-050
|
|
|
|
June 12 |
All Faculty |
Federal |
Career Development |
NCI Mentored Clinical Scientist Research Career
Development Award to Promote Diversity
Clinical scientists from diverse backgrounds committed to a
career in basic biomedical, behavioral or translational cancer
research, including research on cancer health disparities
Due Date:
|
June 12
|
Amount & Project Period:
|
$130,000/yr for 5 years
|
|
Eligibility:
|
Junior Clinical Scientists
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-051
|
|
|
|
June 12 |
All Faculty |
Federal |
Patient-oriented Research |
Mentored Patient-Oriented Research Career
Development Award to Promote Diversity
Funding opportunity offers protected time for investigators to focus on
patient-oriented cancer research (POR)
Due Date:
|
June 12
|
Amount & Project Period:
|
$130,000/yr for 5 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-052
|
|
|
New Opportunity
|
|
June 16 |
All Faculty |
Federal |
Health Literacy |
Understanding and Promoting Health Literacy
Encourage methodological, intervention and dissemination research for understanding and promoting
health literacy.
Due Date:
|
June 16
|
Amount & Project Period:
|
R21:
$275,000 total over 2 years
R03:
$100,000 total over 2 years
|
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
R21:
PAR-13-132
| R03:
PAR-13-131
|
|
|
New Opportunity
|
|
June 16 |
All Faculty |
Federal |
Patient Centered Outcomes |
Dissemination and Implementation Research in Health
Identify, develop, evaluate and refine effective methods, infrastructures, and
strategies to implement research-tested health behavior change interventions,
evidence-based prevention, early detection, diagnostic, treatment and management,
and quality of life improvement services.
Due Date:
|
June 16
|
Amount & Project Period:
|
R21: $275,000 total over 2 years
R03: $100,000 total over 2 years
|
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
R21:
PAR-13-054
| R03:
PAR-13-056
|
|
|
|
June 16 |
All Faculty |
Federal |
All Areas |
Exploratory/Developmental Research Grant Program
Encourage exploratory and developmental projects in all areas of cancer research.
Due Date:
|
June 16
|
Amount & Project Period:
|
$275,000 total over 2 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-145
|
|
|
|
June 16 |
All Faculty |
Federal |
Short-term projects |
Small Grants Program for Cancer Research
Supports small, short-term research projects on cancer.
Due Date:
|
June 16
|
Amount & Project Period:
|
$100,000 total for 1 year
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-144
|
|
|
|
June 16 |
All Faculty |
Federal |
Obesity |
Exploratory/Developmental Clinical Research Grants in Obesity
Obesity has been observed to be associated with increased incidence and mortality of certain cancers,
including breast and colon cancer. The NCI is interested in supporting human intervention studies utilizing
bioactive components (e.g., tea polyphenols, calcium) or variation in diet composition
strategies that evaluate weight change in populations; including individuals with a genetic propensity for cancer as well as those
with cancer or at risk for recurrence of cancer.
Due Date:
|
June 16
|
Amount & Project Period:
|
$275,000 total over 2 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-179
|
|
New Opportunity
|
June 17 (LOI)
July 17 (App) |
All Faculty |
Federal |
Genomic
Medicine |
Genomic Medicine Pilot Demonstration Projects
Support a consortium of collaborative genomic medicine pilot Demonstration
Projects designed to demonstrate the feasibility of, and develop methods for,
incorporating an individual patient's genomic findings into his or her clinical care.
Due Date:
|
June 17 (LOI)
July 17 (App)
|
Amount & Project Period:
|
$750,000 - Year 1
$1,000,000 - Year 2, 3 and 4
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
HG-13-004
|
|
|
New Opportunity
|
June 17 (LOI)
July 17 (App) |
All Faculty |
Federal |
Natural Product
Discovery |
Genomes to Natural Product Discovery
Support projects that use the wealth of genomic and metagenomic sequencing data available, and
recent advances in synthetic biology for the purpose of developing new high-throughput
and broadly applicable approaches to natural products discovery.
Due Date:
|
June 17 (LOI)
July 17 (App)
|
Amount & Project Period:
|
$2.25 million/yr for 5 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RRFA Link:
|
GM-14-002
|
|
New Opportunity |
|
June 18 |
All Faculty |
Federal |
Tobacco Control |
Tobacco Control Regulatory Research
Research that will inform the development and evaluation of regulations on tobacco
product manufacturing, distribution, and marketing.
Due Date:
|
June 18
|
Amount & Project Period:
|
R01: No funding limit - 5 years.
R21: $275,000 total over 2 years.
R03: $100,000 total over 2 years.
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Links:
|
R01:
PAR-12-267
| R21:
PAR-12-266
| R03:
PAR-12-268
|
|
|
|
June 18 |
Sr. Faculty |
Federal |
Clinical Onc
Training Program |
Paul Calabresi Career Development Award
for Clinical Oncology
The purpose of the Paul Calabresi Career Development Award for Clinical Oncology is to increase
the number of clinicians and PhD scientists who are trained to design and test clinical therapeutic
research protocols, conduct patient-oriented cancer therapeutic research in team research environments,
and to support the career development of investigators who have made a commitment to focus their
research endeavors on patient-oriented research.
Due Date:
|
June 18
|
Amount & Project Period:
|
$750,000/yr for 5 years
|
|
Eligibility:
|
Senior Faculty |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-201
|
|
New Opportunity |
June 18
November 18
|
All Faculty |
Federal |
Cancer Biology |
Collaborative Research in Integrative Cancer Biology
To encourage new research into integrative cancer biology by fostering
collaborations between investigators currently supported through the
Integrative Cancer Biology Program (ICBP) and those currently unaffiliated
with the ICBP.
Due Date:
|
June 18
November 18
|
Amount & Project Period:
|
No funding limit - 5 years
|
|
Eligibility:
|
Collaborating teams must be comprised of at
least one ICBP investigator and at least one non-ICBP-affiliated
investigator.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-184
|
|
New Opportunity
|
June 19 (LOI)
Sept 27 (App) |
All Faculty |
Federal |
CDRNs |
The National Patient-Centered Clinical Research Network:
Clinical Data Research Networks (CDRN) - Phase One
Clinical Data Research Networks (CDRNs) that will develop the capacity
to conduct randomized comparative effectiveness studies using data
from clinical practice in a large, defined population.
Due Date:
|
June 3 (Informational Webinar)
June 19 (LOI)
Sept 27 (App)
|
Amount & Project Period:
|
$7,000,000 total over 18 months
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
CDRN - Phase One
|
|
New Opportunity |
June 19
November 19 |
All Faculty |
Federal |
Drug Delivery |
Image-guided Drug Delivery in Cancer
Supports innovative projects focused on image-guided drug delivery (IGDD), including
real-time image guidance, monitoring, quantitative in vivo characterizations and validation
of delivery and response.
Due Date:
|
June 19
November 19
|
Amount & Project Period:
|
No fudning limit - 5 years
|
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-185
|
|
|
New Opportunity
|
June 20
November 20 |
All Faculty |
Federal |
Health
Disparities |
Basic Cancer Research in Cancer Health Disparities
Encourage applications from investigators interested in conducting basic, mechanistic
research into the biologic/genetic causes of cancer health disparities.
Due Date:
|
June 20
November 20
|
Amount & Project Period:
|
$250,000/yr for 5 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-095
|
|
New Opportunity
|
June 26 (Pre-App)
Sept 17 (Submissions) |
All Faculty |
Federal |
Bone Marrow
Failure |
CDMRP-Bone Marrow Failure Research Program Idea Development Award
Supports innovative ideas and high impact approaches to bone marrow
failure research. Proposals may include relevant preliminary data, but
clinical trials will not be supported.
Due Date:
|
June 26 (Pre-App)
September 17 (Submissions)
|
Amount & Project Period:
|
$360,000 direct costs (plus indirect costs)
|
|
Eligibility:
|
All Faculty |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-BMFRP-IDA
|
|
|
|
July 1 |
Postdocs |
Non-Federal |
Career Development |
The Helen Hay Whitney Foundation - Research Fellowships
Supports early postdoctoral research training in basic biomedical sciences.
Due Date:
|
July 1
|
Amount & Project Period:
|
Stipend:
$49,000 total year 1
$50,000 total year 2
$51,000 total year 3
Allowance:
$1,500/yr for 3 years
|
|
Eligibility:
|
Postdoctoral fellows with less than 1 year training and US citizen.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
The Helen Hay Whitney Foundation Research Fellowship
|
|
|
New Opportunity
|
July 15 (LOI)
Aug 15 (App) |
All Faculty |
Federal |
Oral Cancer |
Functional Characterization of Oral Cancer Initiating
Cells
Support translational projects in oral cancer aimed at understanding the cellular, molecular and
functional properties of oral Cancer Initiating Cells (CICs)and their niches.
Due Date:
|
July 15 (LOI)
August 15 (App)
|
Amount & Project Period:
|
R01: No funding limit - 4 years.
R21: $275,000 total over 2 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Links:
|
R01:
RFA-DE-14-001
|
R21: RFA-DE-14-002
|
|
New Opportunity |
|
August 1 |
All Faculty |
Internal |
Infection Cancer |
Center for Infection Research In Cancer (CIRC) Funding Opportunity
An intramural grant program to fund pilot projects that will bring together multidisciplinary strengths of Moffit to meet
the goals of the CIRC.
Due Date:
|
August 1 at 4:00pm
|
Amount & Project Period:
|
$50,000 for 12 months
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Maureen Ahearn, x8824
|
RFA Link:
|
CIRC Website
|
|
New Opportunity |
|
October 14 (LOI)
November 14 (App) |
All Faculty |
Federal |
Microbial Metabolites |
The Role of Microbial Metabolites in Cancer
Prevention and Etiology
Stimulate preclinical and clinical research to describe the effect of microbially
generated metabolites in cancer prevention/progression
Due Date:
|
October 14 (LOI)
November 14 (App)
|
Amount & Project Period:
|
No funding limit - 5 years
|
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-159
|
|
|
|
|
| Toolbox |
|
|
| |
|
|
Questions?
MRISignals@moffitt.org
|
 |
